Longboard Pharmaceuticals Statistics
Total Valuation
PRM has a market cap or net worth of $2.49 billion. The enterprise value is $3.17 billion.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PRM has 147.73 million shares outstanding. The number of shares has increased by 1.57% in one year.
Current Share Class | 147.73M |
Shares Outstanding | 147.73M |
Shares Change (YoY) | +1.57% |
Shares Change (QoQ) | -6.17% |
Owned by Insiders (%) | 6.28% |
Owned by Institutions (%) | 88.04% |
Float | 138.43M |
Valuation Ratios
The trailing PE ratio is 31.78 and the forward PE ratio is 15.54.
PE Ratio | 31.78 |
Forward PE | 15.54 |
PS Ratio | 4.07 |
Forward PS | 4.57 |
PB Ratio | 2.09 |
P/TBV Ratio | n/a |
P/FCF Ratio | 14.66 |
P/OCF Ratio | 12.59 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 21.78, with an EV/FCF ratio of 18.64.
EV / Earnings | 39.84 |
EV / Sales | 5.20 |
EV / EBITDA | 21.78 |
EV / EBIT | 40.79 |
EV / FCF | 18.64 |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.69.
Current Ratio | 4.04 |
Quick Ratio | 2.52 |
Debt / Equity | 0.69 |
Debt / EBITDA | 5.52 |
Debt / FCF | 4.81 |
Interest Coverage | 2.00 |
Financial Efficiency
Return on equity (ROE) is 7.06% and return on invested capital (ROIC) is 2.51%.
Return on Equity (ROE) | 7.06% |
Return on Assets (ROA) | 2.02% |
Return on Invested Capital (ROIC) | 2.51% |
Return on Capital Employed (ROCE) | 3.26% |
Revenue Per Employee | $1.91M |
Profits Per Employee | $249,304 |
Employee Count | 319 |
Asset Turnover | 0.25 |
Inventory Turnover | 1.76 |
Taxes
Income Tax | -38.36M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +65.29% in the last 52 weeks. The beta is 1.96, so PRM's price volatility has been higher than the market average.
Beta (5Y) | 1.96 |
52-Week Price Change | +65.29% |
50-Day Moving Average | 14.76 |
200-Day Moving Average | 12.46 |
Relative Strength Index (RSI) | 63.32 |
Average Volume (20 Days) | 1,032,866 |
Short Selling Information
The latest short interest is 4.59 million, so 3.11% of the outstanding shares have been sold short.
Short Interest | 4.59M |
Short Previous Month | 4.66M |
Short % of Shares Out | 3.11% |
Short % of Float | 3.31% |
Short Ratio (days to cover) | 3.60 |
Income Statement
In the last 12 months, PRM had revenue of $609.32 million and earned $79.53 million in profits. Earnings per share was $0.53.
Revenue | 609.32M |
Gross Profit | 352.77M |
Operating Income | 77.66M |
Pretax Income | -46.98M |
Net Income | 79.53M |
EBITDA | 145.42M |
EBIT | 77.66M |
Earnings Per Share (EPS) | $0.53 |
Full Income Statement Balance Sheet
The company has $140.66 million in cash and $817.99 million in debt, giving a net cash position of -$677.34 million or -$4.58 per share.
Cash & Cash Equivalents | 140.66M |
Total Debt | 817.99M |
Net Cash | -677.34M |
Net Cash Per Share | -$4.58 |
Equity (Book Value) | 1.18B |
Book Value Per Share | 8.08 |
Working Capital | 316.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $197.86 million and capital expenditures -$27.91 million, giving a free cash flow of $169.95 million.
Operating Cash Flow | 197.86M |
Capital Expenditures | -27.91M |
Free Cash Flow | 169.95M |
FCF Per Share | $1.15 |
Full Cash Flow Statement Margins
Gross margin is 57.90%, with operating and profit margins of 12.75% and 13.05%.
Gross Margin | 57.90% |
Operating Margin | 12.75% |
Pretax Margin | 6.76% |
Profit Margin | 13.05% |
EBITDA Margin | 23.87% |
EBIT Margin | 12.75% |
FCF Margin | 27.89% |
Dividends & Yields
PRM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.57% |
Shareholder Yield | -1.57% |
Earnings Yield | 3.19% |
FCF Yield | 6.82% |
Analyst Forecast
The average price target for PRM is $18.50, which is 9.73% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $18.50 |
Price Target Difference | 9.73% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |